Objectives: To determine antioxidant levels in plasma, low density lipoprotein (LDL) and high density lipoprotein (HDL) before and after supplementation with a carotene mixture or lycopene; to examine the interrelationships between carotenoids and tocopherols in plasma, LDL and HDL under normal dietary conditions and after supplementation with carotene or lycopene; and to investigate whether supplementation with a carotene mixture or lycopene could enhance the ability of LDL to withstand oxidative stress in vitro, in a group of healthy elderly people aged ! 65 y. Design: Randomized placebo controlled double blind study. Setting: Free living urban adults in Ireland. Subjects: Fifty-one volunteers aged ! 65 y. Interventions: Volunteers were each provided with capsules providing either 13.3 mg lycopene, or 11.9 mg carotene or placebo for 12 weeks. Results: Both absolute and cholesterol standardized plasma carotenoid concentrations correlated strongly with LDL and HDL concentrations of carotenoids before and after supplementation with carotene or lycopene. Supplementation with a carotene mixture or lycopene had no effect on oxidative modi®cation of LDL in vitro despite signi®cant increases in plasma and LDL concentrations of lycopene, a-carotene and b-carotene.
Introduction
Plasma concentrations of antioxidants vary considerably among healthy individuals (Olmedilla et al, 1994; Street et al, 1994) . Similarly, the antioxidant levels in low density lipoprotein (LDL) show a substantial inter-individual variation (Esterbauer et al, 1993; Frei & Gaziano, 1993) . The atocopherol content of LDL may range from about three to 16 molecules per LDL particle and that of b-carotene can range from 0.03 to about two molecules per LDL particle (Esterbauer et al, 1992) . It is widely accepted that the variability in lipoprotein antioxidant levels is related to plasma antioxidant levels. This has been observed in several vitamin E (Dieber-Rotheneder et al, 1991; Jialal & Grundy, 1992; Princen et al, 1995) and b-carotene (Princen et al, 1992; Reaven et al, 1994) supplementation studies. To date, only one study has examined the relationships between the antioxidant levels in lipoproteins (LDL) and plasma in healthy people who were not taking nutritional supplements (Ziouzenkova et al, 1996) . The relationships between the antioxidant content of plasma and high density lipoprotein (HDL) have not been examined in either unsupplemented or supplemented individuals. HDL is known to inhibit the copper-induced oxidation of LDL in vitro and may also constitute the primary vehicle for transport and clearance of plasma lipid hydroperoxides, thereby preventing their accumulation in LDL (Navab et al, 1991; Bowry et al, 1992) . However, the role of antioxidants in protecting HDL against oxidation remains unclear.
Reports from clinical trials found that oral supplementation with b-carotene resulted in increases in the plasma and lipoprotein concentrations of b-carotene with no effects on other antioxidants (Princen et al, 1992; Ribayo-Mercado et al, 1995) . The increases observed in lipoprotein concentrations of b-carotene correlated strongly with those found in plasma concentrations. Lycopene levels in serum and adipose tissue appear to be inversely associated with the risk of coronary heart disease . Dietary supplementation with lycopene in the form of tomato-containing foods or capsules signi®cantly increased serum lycopene concentrations Palan et al, 1998; Pateau et al, 1998) . Other studies observed that the plasma response to lycopene is affected to a large extent by the matrix in which the lycopene is delivered, eg lycopene appears to be more bioavailable in processed tomato products (tomato paste) rather than raw tomatoes (Stahl & Sies, 1992; Porrini et al, 1998) . The effects of lycopene supplementation on lipoprotein carotenoid concentrations have not been examined. Epidemiologic studies have observed an inverse relationship between the risk of atherosclerosis and plasma levels or dietary intake of antioxidants (Knekt et al, 1994; Morris et al, 1994) . Thus, a better understanding of the relationships between plasma and LDL levels of antioxidants is important in re®ning our knowledge of the relevance of antioxidant status to the lipid oxidation hypothesis. Oxidative modi®cation of LDL is thought to play a pivotal role in atherogenesis, with oxidatively modi®ed LDL resulting in the formation of foam cells . Immunochemical evidence suggests that oxidised LDL exists in vivo (Yla-hertula et al, 1989; Rosenfeld et al, 1990) . Studies of temporal changes in levels of antioxidants during copper-mediated oxidative modi®cation of LDL have shown that ubiquinol-10 disappears ®rst, followed by vitamin E and lastly by the carotenoids (Stocker et al, 1991; Esterbauer et al, 1992) . Following depletion of antioxidants the rate of lipid peroxidation rapidly accelerates. Lipid peroxidation and the subsequent decomposition of lipid hydroperoxides are key events in the modi®cation of LDL, which accumulates in macrophages and results in the formation of foam cells (Esterbauer et al, 1992) . This implies that LDL antioxidants are likely to play a key role in determining the susceptibility of LDL to oxidative modi®cation, and ultimately in the risk for cardiovascular disease. However, several human studies failed to observe any signi®cant effect on the susceptibility of LDL to oxidative modi®cation in vitro after supplementation with b-carotene (Princen et al, 1992; Abbey et al, 1993; Meraji et al, 1997) . On the other hand, studies employing in vitro enrichment of LDL with b-carotene effected a reduction in the susceptibility of LDL to oxidative modi®cation (Jialal et al, 1991; Lavy et al, 1993) . In general, little attention has been given to the cardioprotective effect of other carotenoids.
The objectives of the present study were to determine the antioxidant levels in plasma, LDL and HDL and examine the interrelationships between carotenoids and tocopherols in plasma, LDL and HDL under normal dietary conditions and to determine the effects of supplementation with carotene and lycopene on carotenoid levels in plasma, LDL and HDL. In addition, the interrelationships between carotenoids in plasma, LDL and HDL following 12 weeks supplementation with carotene and lycopene were examined. Finally, the effect of supplementation of elderly volunteers with carotene or lycopene on the ability of LDL to withstand oxidative stress in vitro was examined.
Methods

Study sample
Fifty-eight non-institutionalized volunteers ! 65 y were recruited following screening by medical history, physical examination and biochemical and haematological pro®le. Exclusion criteria were as follows: smoking, serum retinol less than 1 mmolal, those on special diets, taking nutritional supplements or medications known to affect absorption of nutrients, excessive alcohol consumption, underweight or obesity, 10% weight loss over the preceding 6 months, diabetes, arthritis, dementia, gastrointestinal disorders, anaemia, uncontrolled hypertension or hyperlipidaemia. Approval for this study was obtained from the Clinical Research Ethics Committee at University College Cork and informed consent was given by all volunteers.
The mean (AE s.d.) age of the volunteers was 70 AE 5 y and ranged from 63 to 83 y. At screening, plasma fasting total cholesterol, total HDL cholesterol and triacylglycerols were 5.7 AE 0.8, 1.2 AE 0.3 and 1.2 AE 0.5 mmolal, respectively.
Study design
In this placebo-controlled double blind study, subjects were randomized into placebo, carotene and lycopene treatment groups, each receiving one capsule daily for 12 weeks. This study was part of a multicentre study and capsules were prepared by RP Scherer, Florida, USA. Placebo capsules provided 0.5 g corn oil, 0.06 mg a-tocopherol and 0.23 mg g-tocopherol. Lycopene capsules, with Lyc-O-Pen 2 (LycoRed Natural Products Industries Ltd, Israel) as the lycopene source, provided 13.3 mg total lycopene with 11.35 mg as all-trans-lycopene isomer, 3.5 mg a-tocopherol and 2.5 mg g-tocopherol in corn oil excipient. Carotene capsules, with palm fruit (Quest International, The Netherlands) as the source of b-carotene, provided 8.2 mg total b-carotene with 4.9 mg all-trans-b-carotene, 2.42 mg 9-cisb-carotene, 3.7 mg a-carotene and 1.75 mg a-tocopherol in corn oil excipient.
Meetings were held with volunteers on a monthly basis. Compliance was assessed on the basis of questioning volunteers, counting returned capsules and achieving a positive plasma response, the following month's supply of supplements was delivered and the use of other nutritional supplements was checked.
Fasting blood samples were obtained at baseline and following 12 weeks of supplementation. Blood samples were collected into evacuated tubes containing 0.34 M EDTA K 3 for estimation of plasma, LDL and HDL total cholesterol, carotenoids, tocopherols and determination of oxidative modi®cation of LDL. The samples were protected from natural light. The samples were centrifuged at 720 g for 30 min at room temperature to isolate the plasma fraction. Plasma thus obtained was stored at 770 C until analysed.
Preparation of LDL and HDL LDL and HDL were prepared immediately after thawing by a rapid isolation technique involving a single spin discontinuous density gradient ultracentrifugation method (Chung et al, 1986) . Two tubes were prepared for each volunteer. Plasma (2.7 mmol EDTA) adjusted to density (d) 1.3 gaml with solid KBr (1.5 ml) was overlayered with density solution (1.006 gaml) in Optiseal Ultracentrifuge tubes (Beckman Instruments, Palo Alto, California). The tubes were centrifuged at 645,000 g for 90 min at 7 C, acceleration 6 and deceleration 8 using an NVT 90 nearvertical rotor in an Optima XL-90 ultracentrifuge (Beckman Instruments, Palo Alto, California). Tubes were sliced to obtain the LDL and HDL fractions. The HDL fractions from both Optiseal tubes were pooled, aliquots were removed for protein and cholesterol assays and the Lipoprotein carotenoid pro®les YL Carroll et al remainder of the sample was frozen at 770 C and used for estimation of carotenoids and tocopherols. An aliquot of LDL from one tube was removed for immediate protein and cholesterol estimation and the remainder was frozen at 770 C for estimation of carotenoids and tocopherol. LDL isolated from the other tube was prepared for analysis of conjugated diene production in response to stimulation of oxidative modi®cation by incubation with copper sulphate. This LDL was centrifuged with density solution (d 1.063 gaml) under the same conditions to eliminate contamination with albumin. The top layer containing LDL was removed by tube slicing.
Oxidative modi®cation of LDL LDL samples were dialyzed at 4 C, in the dark against 10 L of phosphate buffered saline (PBS) containing 10 mM EDTA Na 2 , pH 7.4 for 24 h, while shaking in a microdialysis unit (GibcoBRL, Scotland). Aliquots of dialysed LDL were removed for analysis of protein concentration (Markwell et al, 1981) . Samples were adjusted to a protein concentration of 125 mg LDL proteina250 ml with PBS (pH 7.4, 10 mM EDTA) in quartz cuvettes and were then diluted 10-fold by addition of 2250 ml EDTA-free, Chelex 1 100 resin-treated (BioRad Laboratories, California, USA) PBS to give samples of concentration 50 mg LDL proteinaml and 1 mM EDTA (Kleinveld et al, 1992) . In vitro oxidation of LDL was initiated by addition of copper sulphate at a ®nal concentration of 15 mM (Kleinveld et al, 1995) . Absorbance of the samples was monitored at wavelength 234 nm, every 2 min at 30 C in a Cary IE Varian spectrophotometer with cell-changer and Peltier heater accessories (Cary Varian, Australia). Lag phase, maximal rate of conjugated diene production and maximum concentration of conjugated dienes were estimated, using exact co-ordinates provided by the kinetics software application (Cary Varian, Australia).
Determination of plasma, LDL and HDL carotenoids
Plasma, LDL and HDL carotenoids were extracted according to the method of Burton et al, (1985) . Plasma carotenoids were extracted from 0.2 ml of plasma. LDL carotenoids were extracted from 0.6 ml LDL of concentration 400 mg LDL proteinaml PBS and were reconstituted in 20 ml dichloromethane followed by 180 ml acetonitrile:methanol (75:20, by volume). HDL carotenoids were extracted from 0.4 ml HDL and were reconstituted in 20 ml dichloromethane followed by 180 ml acetonitrile:methanol (75:20, by volume). Analysis of carotenoids and tocopherols was carried out by reverse-phase HPLC as described by Scott and Hart (1993) . Samples were protected from natural light. The data were processed using Millennium 2.1 software data processing package (Waters Corporation, Milford, USA). Six carotenoids including lutein, zeaxanthin, b-cryptoxanthin, all-trans lycopene, acarotene and all-trans b-carotene were quanti®ed by reference to ®ve-point calibration curves. a-Tocopherol and gtocopherol were also measured. For each subject, duplicate pre-and post-treatment plasma or LDL samples were run on the same day. Plasma carotenoids were expressed in both absolute amounts and cholesterol standardized amounts. The antioxidant content of LDL and HDL was expressed in terms of cholesterol (nmolamg cholesterol) and also on a molar basis in molecules per LDL and HDL particle. Taking 2.5 million as the mean molecular weight of LDL and a mean cholesterol content of 34.7% (Esterbauer et al, 1992), the antioxidant content of LDL in moles per moles was calculated. Likewise, taking 2.65610 5 as the mean molecular weight of HDL (Goulinet & Chapman, 1997) , with a cholesterol content of 35% (Bowry et al, 1992) , the antioxidant content was expressed on a molar basis in molecules per HDL particle.
Other analytical methods Plasma total cholesterol and total cholesterol of the isolated LDL and HDL were determined using a diagnostic kit supplied by Boehringer Mannheim, Germany. Protein concentration of both LDL and HDL fractions were determined by a modi®ed version of the Lowry assay (Markwell et al, 1981) .
Statistical analysis
Following screening, 58 eligible volunteers were recruited and 47 were included in the statistical analysis. Three volunteers did not complete the study, and the remainder were excluded for poor compliance, commencing supplementation with other nutrients, or loss of sample during laboratory handling.
Analysis of covariance (ANCOVA) was used to test for differences between the treatment groups at the end of the treatment period with post-treatment as the dependent variable, treatment group as the ®xed factor and the pretreatment assigned as covariate. The ®rst step in this general linear models analysis included treatment group and pre-treatment as main effects and included a two-way, treatment group6pre-treatment interaction term. Following this step, ANCOVA was repeated without the interaction term if the interaction was not signi®cant at the 1% level. If the treatment group effect was signi®cant at the 1% level when the interaction term was omitted, post-hoc Bonferroni tests with adjustment for multiple comparisons were performed on post-treatment variables. If the interaction term was signi®cant, a plot of pre-treatment against post-treatment variables was examined for trends in the data. If outliers were obvious, they were removed and the analysis repeated.
In order to avoid any misinterpretation that could be introduced by parameters other than those measured, the present study uses the cholesterol standardized antioxidant content in LDL and HDL in the analysis of the relationships between plasma and LDL and plasma and HDL. Spearman's rank correlation coef®cients were calculated to determine the relationship between plasma concentrations of antioxidants (expressed in both absolute amounts and standardized for cholesterol) and antioxidant concentrations in LDL and HDL expressed per mg of cholesterol. Statistical analysis was performed with datadesk 4.2 (Data Description Inc., New York, USA) and SPSS (SPSS Inc., Chicago, USA) statistical software packages.
Results
Characteristics of the study population are shown in Table  1 . There were no signi®cant differences between the groups with respect to age, BMI, total cholesterol, triacylglycerols and HDL cholesterol. Volunteers were in good health and had normal values of other biochemical variables (eg liver function tests, urea and electrolytes (data not shown)) and haematological values (eg red blood cells, haematocrit and platelet count (data not shown)).
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The antioxidant content in plasma of the whole group is shown in Table 2 . Plasma total cholesterol concentrations correlated with plasma a-tocopherol (r 0.46, P 0.001), b-carotene (r 0.31, P 0.04), lutein (r 0.45, P 0.001) and zeaxanthin (r 0.32, P 0.03). Plasma total cholesterol concentrations did not correlate signi®cantly with acarotene, lycopene, b-cryptoxanthin or g-tocopherol.
Mean LDL and HDL antioxidant concentrations for the whole group are presented in Table 3 . In the unsupplemented group there were strong positive correlations between LDL and plasma carotenoid levels (r 0.59 ± 0.88, P`0.001) and between LDL and plasma cholesterol-standardized carotenoid levels (r 0.58 ± 0.87, P`0.001). The strongest correlations between plasma and LDL carotenoids were observed for lycopene and b-cryptoxanthin (r 0.87, P`0.001). Positive correlations were observed between LDL and plasma a-tocopherol levels (r 0.34, P 0.02) and between LDL and plasma cholesterol-standardized a-tocopherol levels (r 0.35, P 0.01). A stronger correlation was observed between the g-tocopherol content of LDL and the absolute plasma g-tocopherol concentrations (r 0.49, P`0.001) and also with the cholesterol standardized g-tocopherol concentrations (r 0.55, P`0.001). Signi®cant correlations were also observed between the carotenoid content in HDL and both the absolute plasma carotenoid concentrations (r 0.51 ± 0.83, P`0.001) and cholesterol standardized plasma carotenoid concentrations (r 0.51 ± 0.84, P`0.001). The strongest correlation between HDL and plasma carotenoids was observed for b-cryptoxanthin (r 0.84, P`0.001). The a-tocopherol content of HDL showed a positive correlation with the absolute plasma atocopherol concentration (r 0.42, P 0.003), but no signi®cant correlation was observed with the cholesterol standardized plasma a-tocopherol (r 0.26, P 0.08). On the other hand, the g-tocopherol content of HDL showed a strong signi®cant correlation with both the absolute plasma g-tocopherol concentrations (r 0.74, P`0.001) and the cholesterol standardised plasma g-tocopherol concentrations (r 0.66, P`0.001).
Mean a-carotene, b-carotene and lycopenc concentrations in plasma, LDL and HDL for the placebo group, carotene and lycopene supplemented groups are presented in Table 4 . Concentrations of the carotenoids did not differ signi®cantly between the three groups at baseline. In the lycopene supplemented group, plasma, LDL and HDL concentrations of lycopene were signi®cantly higher (P`0.0001) than in the other groups. Similarly, supplementation with carotene signi®cantly (P`0.0001) increased the levels of a-carotene and b-carotene in plasma, LDL and HDL fractions. Levels of a-and gtocopherol, b-cryptoxanthin, lutein and zeaxanthin were not affected by supplementation with either carotene or lycopene (data not shown). Table 5 examines relationships between plasma and LDL and HDL concentrations before and after supplementation with lycopene or carotene. Supplementation with lycopene resulted in increases in LDL and HDL lycopene concentrations, which were positively associated with plasma lycopene concentrations. Following supplementation with carotene, increases in LDL and HDL concentrations of a-and b-carotene also correlated strongly with the increases observed in plasma.
The data in Table 6 show that supplementation with either carotene or lycopene did not affect the maximal rate of conjugated diene production or the maximum conjugated diene concentration. The lag phase before the onset of rapid conjugated diene production did not differ between treatment groups following supplementation (P 0.397). 
Discussion
In this healthy elderly population, plasma concentrations of b-carotene, lutein, zeaxanthin and a-tocopherol were positively associated with plasma cholesterol concentrations. No relationships were observed between the plasma concentrations of lycopene, a-carotene, b-cryptoxanthin or gtocopherol and plasma cholesterol. In the present study, LDL and HDL levels of carotenoids and tocopherols, expressed on a molar basis, were comparable to the levels found in other studies (Romanchik et al, 1995; Goulinet & Chapman, 1997) . The results of the present study show that HDL is virtually devoid of carotenoids. Each molecule of HDL contains approximately two molecules of a-tocopherol and approximately 57 of every 1000 HDL molecules contain carotenoid. HDL has been reported to protect against cardiovascular disease through a number of mechanisms, including the inhibition of copper mediated oxidation of LDL, and by also constituting the primary vehicle for transport and clearance of plasma lipid hydroperoxides thereby prevent their accumulation in LDL (Navab et al, 1991; Bowry et al, 1992) . Thus, the relevance of the antioxidant content of HDL to its antiatherogenic action remains unclear. Based on the present data LDL contains approximately 10 molecules of a-tocopherol per molecule and approximately 60% of LDL molecules in plasma contain carotenoid. This agrees with the ®ndings of Goulinet and Chapman (1997) , who found that LDL contains approximately nine molecules of a-tocopherol per molecule of LDL and approximately 70% of LDL molecules in plasma contain carotenoid. The present study suggests that, in unsupplemented individuals, plasma levels of carotenoids predict the carotenoid content of LDL and HDL. Overall, the magnitude of the correlations between LDL and plasma carotenoid concentrations compared well with those reported elsewhere in unsupplemented people (Ziouzenkova et al, 1996) . The weak correlation observed between a-tocopherol content of LDL and plasma a-tocopherol is in line with other data for unsupplemented people (Ziouzenkova et al, 1996) . However, other studies (Dieber-Rotheneder et al, 1991; Jialal & Grundy, 1992; Princen et al, 1995) showed that in vitamin E-supplemented people, the increases in LDL a-tocopherol levels correlated with the increases in plasma a-tocopherol. This suggests that the atocopherol content of LDL may not be the exclusive determinant for the inverse relationship between plasma a-tocopherol and the risk of cardiovascular disease, and that other effects such as decreased platelet adhesion and aggregation, smooth muscle cell proliferation, and monocyte adhesion could be major mechanisms (Morrissey & Sheehy, 1999) . The correlation observed for g-tocopherol (r 0.55, P`0.001) concentrations between LDL and plasma in the present study, agrees with the ®ndings of Ziouzenkova et al (1996) . No relationship was observed between the a-tocopherol content of HDL and the standardized plasma a-tocopherol concentrations. In contrast, strong positive correlations were also observed between HDL g-tocopherol concentrations and plasma standardized g-tocopherol concentrations. Recently it has been demonstrated that g-tocopherol plays a role in the inhibition of peroxynitrite-induced lipid peroxidation and may therefore function in the prevention of cardiovascular disease (Christen et al, 1997) . Thus, there is a need to further evaluate the potential relationship between vitamin E, in particular g-tocopherol, and cardiovascular disease.
Supplementation with lycopene for 12 weeks produced changes in plasma, LDL and HDL concentrations of lycopene with no effects on the concentrations of other carotenoids or tocopherols. These results are in line with those of Pateau et al (1998) . The present study is the ®rst to examine the effects of lycopene supplementation on lipoprotein lycopene concentrations. The data shows that increases observed in the LDL and HDL concentrations of lycopene correlated strongly with the increases observed in plasma lycopene concentrations.
The present study observed signi®cant increases in the concentrations of both a-and b-carotene in plasma, LDL and HDL following supplementation with carotene for 12 weeks. The increases observed in the concentrations of aand b-carotene in LDL and HDL correlated strongly with increases observed in plasma. These results support the assumption that the variability in the antioxidant content of LDL may be related to the plasma antioxidant levels. This observation is also supported by several supplementation studies with b-carotene (Princen et al, 1992; Reaven et al, 1994; Gaziano et al, 1995) and by epidemiological studies which showed that the incidence of atherosclerosis is inversely related to the dietary intake of antioxidants (Gaziano & Hennekens, 1994) or plasma antioxidant concentrations (Gey, 1993) .
In this study, treatment of elderly volunteers with carotene or lycopene for 12 weeks did not improve the ability of LDL to withstand oxidative stress in vitro, despite substantial increases in plasma and LDL carotenoid concentrations. Enhanced resistance of LDL to oxidative modi®cation following supplementation with these compounds was expected for several reasons. At the molecular level, lycopene and b-carotene have singlet oxygen scavenging capabilities, are highly reactive towards peroxyl radicals and are effective in reducing the concentration of chain-carrying peroxyl radicals at low partial pressures of oxygen (Burton & Ingold, 1984; di Mascio et al, 1989) . Furthermore, a number of studies showed that enrichment of LDL with b-carotene gave increased protection to LDL because several indices of peroxidation, including TBARS, cellular uptake of oxidized LDL by macrophages (Jialal et al, 1991; Lavy et al, 1993) , breath-pentane output and plasma phosphatidylcholine hydroperoxides (Meydani et al, 1994; Allard et al, 1994; Meraji et al, 1997) , were reduced. Supplementation with lycopene, in the form of tomato products and capsules, resulted in decreased production of LDL-TBARS and LDL-conjugated dienes in a group of healthy people aged 25 ± 40 y . However, in line with the present results, several other studies failed to observe an effect of b-carotene supplementation on LDL oxidation as indicated by LDL lag time, LDL oxidation rate or conjugated diene production (Princen et al, 1992; Abbey et al, 1993; Meraji et al, 1997) . Also, Abbey et al (1995) observed that incorparation of carotenoid-rich foods in the diet did not increase the LDL lag phase, or reduce the maximal rate of LDL oxidation, and in addition no correlations were found between the measures of LDL oxidation and plasma bcarotene levels. The mathematical model of Esterbauer et al (1992) would also suggest that carotenoids may not be signi®cant in protecting LDL against oxidative stress.
The evidence from the present study and other studies indicates that protection of LDL against oxidative Lipoprotein carotenoid pro®les YL Carroll et al modi®cation may not be the critical mechanism in protection against atherosclerotic vascular disease. Shaish et al (1995) observed that all-trans b-carotene signi®cantly reduced the extent of atherosclerotic lesions without altering the susceptibility of LDL to oxidation. They proposed that metabolites derived from all-trans b-carotene inhibit atherosclerosis possibly via stereospeci®c interactions with retinoic acid receptors in the artery wall. The work of Faruqui et al (1994) also showed that protection afforded by a-tocopherol against the injurious action of oxidised-LDL was solely a function of the tissue a-tocopherol content and was not related to the prevention of LDL oxidation by a-tocopherol. Other data from Kleinveld et al (1995) , Keaney et al (1996) and Spranger et al (1998) support the hypothesis that in vitro oxidation of single isolated lipoproteins (LDL) may not be a good marker of cardiovascular disease risk. Thus, the bene®cial effects of high antioxidant micronutrient intake may be related to the levels present in speci®c tissues and be independent of the antioxidant protection of LDL as proposed by Keaney et al (1996) .
